Article Details

Statera Biopharma Receives Notification Letter from Nasdaq Regarding Form 10-K Filing

Retrieved on: 2022-04-22 22:03:51

Tags for this article:

Click the tags to see associated articles and topics

Statera Biopharma Receives Notification Letter from Nasdaq Regarding Form 10-K Filing. View article details on hiswai:

Excerpt

FORT COLLINS, Colo., April 22, 2022 (GLOBE NEWSWIRE) -- Statera Biopharma (Nasdaq: STAB) (the “Company”), a biopharmaceutical company creating ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up